List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Tourette Syndrome Drug Product Introduction
1.2 Global Tourette Syndrome Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Tourette Syndrome Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Tourette Syndrome Drug Sales in Volume for the Year 2017-2028
1.3 United States Tourette Syndrome Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Tourette Syndrome Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Tourette Syndrome Drug Sales in Volume for the Year 2017-2028
1.4 Tourette Syndrome Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Tourette Syndrome Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Tourette Syndrome Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Tourette Syndrome Drug Market Dynamics
1.5.1 Tourette Syndrome Drug Industry Trends
1.5.2 Tourette Syndrome Drug Market Drivers
1.5.3 Tourette Syndrome Drug Market Challenges
1.5.4 Tourette Syndrome Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Tourette Syndrome Drug Market Segment by Type
2.1.1 AZD-5213
2.1.2 CPP-115
2.1.3 Dutetrabenazine ER
2.1.4 Ecopipam Hydrochloride
2.1.5 Others
2.2 Global Tourette Syndrome Drug Market Size by Type
2.2.1 Global Tourette Syndrome Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Tourette Syndrome Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Tourette Syndrome Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Tourette Syndrome Drug Market Size by Type
2.3.1 United States Tourette Syndrome Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Tourette Syndrome Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Tourette Syndrome Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Tourette Syndrome Drug Market Segment by Application
3.1.1 Research Center
3.1.2 Hospital
3.1.3 Clinic
3.1.4 Others
3.2 Global Tourette Syndrome Drug Market Size by Application
3.2.1 Global Tourette Syndrome Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Tourette Syndrome Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Tourette Syndrome Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Tourette Syndrome Drug Market Size by Application
3.3.1 United States Tourette Syndrome Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Tourette Syndrome Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Tourette Syndrome Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Tourette Syndrome Drug Competitor Landscape by Company
4.1 Global Tourette Syndrome Drug Market Size by Company
4.1.1 Top Global Tourette Syndrome Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Tourette Syndrome Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Tourette Syndrome Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Tourette Syndrome Drug Price by Manufacturer (2017-2022)
4.2 Global Tourette Syndrome Drug Concentration Ratio (CR)
4.2.1 Tourette Syndrome Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Tourette Syndrome Drug in 2021
4.2.3 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Tourette Syndrome Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Tourette Syndrome Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Tourette Syndrome Drug Product Type
4.3.3 Date of International Manufacturers Enter into Tourette Syndrome Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Tourette Syndrome Drug Market Size by Company
4.5.1 Top Tourette Syndrome Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Tourette Syndrome Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Tourette Syndrome Drug Sales by Players (2020, 2021 & 2022)
5 Global Tourette Syndrome Drug Market Size by Region
5.1 Global Tourette Syndrome Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Tourette Syndrome Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Tourette Syndrome Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Tourette Syndrome Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Tourette Syndrome Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Tourette Syndrome Drug Sales in Value by Region: 2017-2022
5.3.2 Global Tourette Syndrome Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Tourette Syndrome Drug Market Size YoY Growth 2017-2028
6.1.2 North America Tourette Syndrome Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Tourette Syndrome Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Tourette Syndrome Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Tourette Syndrome Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Tourette Syndrome Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Tourette Syndrome Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Tourette Syndrome Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Tourette Syndrome Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abide Therapeutics Inc
7.1.1 Abide Therapeutics Inc Corporation Information
7.1.2 Abide Therapeutics Inc Description and Business Overview
7.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
7.1.5 Abide Therapeutics Inc Recent Development
7.2 Catalyst Pharmaceuticals Inc
7.2.1 Catalyst Pharmaceuticals Inc Corporation Information
7.2.2 Catalyst Pharmaceuticals Inc Description and Business Overview
7.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
7.2.5 Catalyst Pharmaceuticals Inc Recent Development
7.3 Neurocrine Biosciences Inc
7.3.1 Neurocrine Biosciences Inc Corporation Information
7.3.2 Neurocrine Biosciences Inc Description and Business Overview
7.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Products Offered
7.3.5 Neurocrine Biosciences Inc Recent Development
7.4 Psyadon Pharmaceuticals Inc
7.4.1 Psyadon Pharmaceuticals Inc Corporation Information
7.4.2 Psyadon Pharmaceuticals Inc Description and Business Overview
7.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
7.4.5 Psyadon Pharmaceuticals Inc Recent Development
7.5 Reviva Pharmaceuticals Inc
7.5.1 Reviva Pharmaceuticals Inc Corporation Information
7.5.2 Reviva Pharmaceuticals Inc Description and Business Overview
7.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
7.5.5 Reviva Pharmaceuticals Inc Recent Development
7.6 Synchroneuron Inc
7.6.1 Synchroneuron Inc Corporation Information
7.6.2 Synchroneuron Inc Description and Business Overview
7.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Synchroneuron Inc Tourette Syndrome Drug Products Offered
7.6.5 Synchroneuron Inc Recent Development
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
7.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Products Offered
7.7.5 Teva Pharmaceutical Industries Ltd Recent Development
7.8 Therapix Biosciences Ltd
7.8.1 Therapix Biosciences Ltd Corporation Information
7.8.2 Therapix Biosciences Ltd Description and Business Overview
7.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Products Offered
7.8.5 Therapix Biosciences Ltd Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Tourette Syndrome Drug Industry Chain Analysis
8.2 Tourette Syndrome Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Tourette Syndrome Drug Distributors
8.3 Tourette Syndrome Drug Production Mode & Process
8.4 Tourette Syndrome Drug Sales and Marketing
8.4.1 Tourette Syndrome Drug Sales Channels
8.4.2 Tourette Syndrome Drug Distributors
8.5 Tourette Syndrome Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
